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A B S T R A C T
Superior sagittal sinus thrombosis is a rare and often misdiagnosed disorder. Its occurrence with pulmonary embolism (PE) is 
much rarer, more so when it occurs in the setting of puerperium. Although cerebral sagittal sinus thrombosis can occur at any 
time during life, women are particularly vulnerable before delivery and during the puerperal period due to the hypercoagulable 
state of pregnancy. We report a case which describes the challenging clinical course of a young woman who developed superior 
sagittal sinus thrombosis and PE during puerperium.
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INTRODUCTION
Superior sagittal sinus thrombosis is a relatively rare and 
often misdiagnosed condition. Its occurrence simultaneously 
with pulmonary embolism (PE) is much rarer. In general, the 
incidence of cerebral venous thrombosis, of which superior 
sagittal sinus thrombosis is a type, is estimated to be around 
0.22/100,000/year in adults,[1] and 11.6/100,000/year in 
obstetric patients.[2] Western studies have shown relative 
rarity of puerperal cerebral venous thrombosis; Carroll et al.[3] 
and Cross et al.[4] independently reported the incidence of 
cerebral venous thrombosis to be 1 in 2500 deliveries.
Because superior sagittal sinus thrombosis often presents 
with diverse set of symptoms that makes diagnosing it a 
huge task, it commonly poses diagnostic challenges such 
that it can be easily missed or mistaken for more common 
neurological conditions. Thus, a high level of suspicion is 
required for its diagnosis and management.
Although recognized for more than 100 years,[5] it has only in 
recent years come to be diagnosed frequently ante‑mortem. 
This is partly due to greater awareness among physicians 
and neurologists and partly due to improved non‑invasive 
imaging techniques.[6]
The mechanism by which cerebral venous thrombosis manifests 
can be broadly classified into two. First, there could be 
thrombosis of cerebral veins or dural sinus leading to cerebral 
parenchymal lesions or dysfunction. Second, there may be 
occlusion of the dural sinus and consequently reduced cerebral 
spinal fluid absorption and elevated intracranial pressure.[7]
Although sagittal sinus thrombosis like cerebral venous 
thrombosis can occur at any time during life, women 
are particularly vulnerable before delivery and during 
the postpartum period because of the hypercoagulable 
state that accompanies pregnancy. PE from a dural sinus 
thrombosis is uncommon but when it coexists with sinus 
thrombosis it often carries a poor prognosis.[6]
Postpartum or puerperal sagittal sinus thrombosis 
associated with PE is a rare clinical entity. We present a 
case of a woman who developed superior sagittal sinus 
thrombosis associated with PE during puerperal period.
CASE REPORT
This was a case report of a 25‑year‑old Nigerian woman 
who presented to the emergency unit with the major 
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complaint of severe headache, right sided weakness, double 
vision, impaired vision and progressive deterioration of her 
consciousness level that occurred 3 days after a normal 
spontaneous vaginal delivery of her first baby. She had 
an uneventful period of pregnancy; she had spontaneous 
delivery at 40 weeks of gestational age. She was neither 
hypertensive nor diabetic. She had no signs of infection, 
deep vein thrombosis (DVT) or eclampsia during pregnancy. 
She had no pregnancy in the past or history of contraceptive 
use. There was no significant past medical history.
On admission, she had no edema of the extremities, her 
temperature was 36.8°C and body mass index was 20 kg/m2, 
she was drowsy and had mild right hemiparesis (power 
grade 4). She had cranial nerve sixth and seventh palsy, 
her pupils were 2‑3 mm, she had prompt pupillary reflex 
bilaterally and bilateral papilledema. No abnormality was 
detected on other systemic examinations. All hematologic, 
rheumatologic and cardiologic work‑ups including 
electrolytes, blood count, coagulation test and renal 
function test were within the normal limits.
The initial diagnosis was left hemispheric stroke? Cause 
and she was managed accordingly (mannitol, clopidrogel 
and physiotherapy). After 3 days on admission, she became 
breathless; there were no features suggestive of aspiration 
or DVT, no associated cough, orthopnea or paroxysmal 
nocturnal dyspnea. She also developed an episode of 
generalized tonic clonic seizure while on admission. Chest 
examination showed tachypnea (respiratory rate of 36/min) 
however her breath sound was vesicular and there was no 
added sound. Oxygen saturation level was 80% at room air, 
Doppler ultrasound for DVT in the lower limbs was normal 
bilaterally and the D‑dimer was elevated (3.2 µg/mL).
Pulmonary thromboembolism was suspected. The diagnosis 
was also upheld by the chest physician and clinical 
hematologist.
Brain computerized tomography (CT) was inconclusive, 
T1‑weighted and T2‑weighted magnetic resonance 
imaging (MRI)
showed a hyperintense signal from the thrombosed sagittal 
sinus [Figure 1]. The patient was further managed with 100% 
oxygen, carbamazepine, intravenous heparin and warfarin, 
keeping international normalized Ratio between 2.5 and 
3.5. She is currently in a stable clinical state.
DISCUSSION
Diagnosis of cerebral sinus vein thrombosis, including 
superior sagittal sinus thrombosis, has always been 
difficult. Many times, diagnosis of the superior sagittal 
sinus thrombosis was observed only at autopsy, thereby 
raising the suspicion that it is very often a lethal 
neurological disorder.[8] The first case of puerperal sagittal 
sinus thrombosis was described by Abercrombie in 1828[9] 
and in 1829, Tonnelle[10] published a review on the subject. 
The epidemiology of superior sagittal sinus thrombosis 
disease has evolved considerable during recent decades 
with the current predilection involving primarily young and 
middle‑aged people.[11]
Presentation of sagittal sinus thrombosis may be acute, 
which occur within 48 h, sub‑acute, which occur between 
2 days and 1 month and chronic which occur after more 
than 30 days.
Acute presentation is known to be commoner in puerperal 
cases than in non‑puerperal patients[12] which possibly 
explains acute occurrence of the symptoms in our patient. 
Nonetheless, gradual increase in symptoms and a fluctuating 
course is commonly seen in cerebral venous thrombosis 
from other causes.[11]
The index patient presented few days after delivery. 
Puerperal or postpartum period is reported as a risk factor 
for superior sagittal sinus thrombosis and other cerebral 
venous thrombosis.
Potential risk factors for peripartum cerebral venous 
thrombosis and stroke were evaluated in a study conducted 
on United State National Hospital Discharge Survey data 
between 1979 and 1991. The study also identified an 
increased risk of peripartum cerebral venous thrombosis 
in younger women and in women during puerperal period 
particularly those that had a cesarean delivery.[2,13] Needless 
to state that, generally, pregnant women are 4‑5 times 
more likely to develop venous thromboembolism than 
women who are not pregnant.[14] The predisposition to 
Figure 1: T1‑weighted magnetic resonance imaging showing a hyperintense 
signal from the thrombosed sagittal sinus
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develop venous thromboembolism occurs as a result of the 
hypercoagulable state of pregnancy that has likely evolved 
to protect women from hemorrhage during miscarriage and 
childbirth.[15]
Apart from puerperium, the other risk factors for superior 
sagittal sinus include pregnancy, oral contraceptive use, 
cancer, hypercoagulable state, myoma uteri, vasculitis, 
inflammatory bowel disease, head trauma, intracranial 
or systemic infections, dehydration, substance abuse and 
Behcet’s disease.[16,17]
The mode of initial presentation in the index case agrees 
with what obtains in the previously reported cases in 
the literature. The most common presenting symptom is 
headache (80‑90%) that could be isolated in up to 5% of 
cases.[17,18] In the International Study on Cerebral Vein and 
Dural Sinus Thrombosis, focal or generalized seizures and 
paresis were seen in up to 40% of patients, a figure that is 
far higher than in cohort of patients with arterial stroke. 
Papilledema was also present in around 30% while visual 
loss was seen in 13%. Mental status change and aphasia 
were reported in around 20% of patients and approximately 
10% presented with coma.[17‑19] Our patient had all the 
aforementioned symptoms, however, the initial diagnosis 
of arterial stroke was made because the symptom complex 
with which the patient presented with is more commonly 
seen in patients with arterial stroke, emphasizing the fact 
that a high index of suspicion is required to make the right 
diagnosis of superior sagittal sinus thrombosis.
Our patient also had features suggestive of PE. Given that 
she did not have any of the well‑established risk factors for 
a PE such as long bone fractures, DVT, hypercoagulability 
and prolonged immobilization, hence, the possibility that 
her PE could have resulted from superior sagittal sinus 
thrombosis.
The association of sagittal sinus thrombosis and PE may be 
related to a detached thrombus from the cranial venous sinus 
and subsequent embolization to the lung through the venous 
system. The combination, though very rare, appears to have 
been forgotten and was alluded to by Diaz et al., as “a syndrome 
rediscovered in their report.”[20] Because neurological 
symptoms appeared earlier than those of the respiratory 
symptoms, we think that the sagittal sinus thrombosis might 
have formed before the pulmonary thrombus.
Earlier studies showed that it is possible for venous 
thrombus to break off and embolise to the lungs resulting in 
PE.[16,21] This situation is said to occur in about 10% of cases 
but carries a poor prognosis.[20] In a review of the literature 
covering between 1942 and 1990, 11.3% of cases of venous 
sinus thrombosis were associated with pulmonary emboli 
and mortality was higher in those with associated embolism 
than in those without embolism.[20] Therefore, even in 
patients with no evidence of systemic thrombosis, but who 
have sagittal sinus thrombosis, the possibility of dislodging 
pulmonary emboli should be strongly considered.[14]
As seen in our patient, the confirmation of a diagnosis of 
sagittal sinus thrombosis is based on demonstration of 
the thrombus by neuroimaging. Contrast axial CT images 
may show the “typical” empty delta sign, however, this is 
seen only in 20% of cases.[22] Like in the index case, MRI 
is usually the investigation of choice for demonstrating 
sagittal sinus thrombosis, as it may exclude significant 
alternative diagnoses and will also demonstrate cerebral 
venous infarction complicating cerebral venous occlusion.[6] 
Nonetheless, difficulties in diagnosis arise due to unusual 
normal anatomical variants and in situations where there is 
near‑occlusion of the sagittal sinus.[23]
The patient was treated with intravenous heparin and 
warfarin. Heparin and warfarin administration is the 
standard treatment for superior sagittal sinus thrombosis. 
This therapy, which is generally continued until the patient 
stabilizes does not aim at lysing the sinus thrombus, rather, it 
prevents new thrombus formation.[24,25] However, intracranial 
hemorrhage is a significant potential consequence of this 
therapy; thus, the benefits of anticoagulation must be 
carefully balanced against the risks of hemorrhage. Up to 
date, there has not been strong evidence in support of an 
alternative treatment modality; endovascular thrombolysis, 
over anticoagulation therapy for the management of central 
venous sinus thrombosis.[26]
Although the clinical presentation is highly variable, the 
diagnosis of superior sagittal thrombosis sinus as well as other 
central venous sinus thrombosis should be given consideration 
in a young and middle‑aged woman in puerperal period with 
recent unusual headache or focal neurological deficit in the 
absence of the usual vascular risk factors.
CONCLUSION
The case presented demonstrated that sagittal sinus 
thrombosis may present during puerperium to the 
obstetrician and physician in a number of ways. High 
index of suspicion is required for its diagnosis which can 
be confirmed using MRI technique in most cases and even 
though it occurs rarely, PE should be watched out for in 
such patients. It also highlighted the consideration of 
sagittal sinus thrombosis in a patient who may present with 
clinical signs and symptoms of stroke during the puerperium 
especially in resource poor settings where neuroimaging 
may be a challenge.
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